Microbot Medical (NASDAQ:MBOT) Stock Passes Above 200 Day Moving Average – What’s Next?

Microbot Medical Inc. (NASDAQ:MBOT)’s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.26 and traded as high as $1.54. Microbot Medical shares last traded at $1.44, with a volume of 469,348 shares trading hands.

Analyst Upgrades and Downgrades

Separately, HC Wainwright raised their target price on shares of Microbot Medical from $7.00 to $9.00 and gave the stock a “buy” rating in a research note on Friday, January 24th.

Microbot Medical Price Performance

The company has a market cap of $50.03 million, a price-to-earnings ratio of -1.80 and a beta of 1.60. The firm has a 50-day moving average price of $1.83 and a 200 day moving average price of $1.26.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Microbot Medical stock. Geode Capital Management LLC increased its holdings in shares of Microbot Medical Inc. (NASDAQ:MBOT) by 7.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 142,659 shares of the biotechnology company’s stock after acquiring an additional 10,442 shares during the quarter. Geode Capital Management LLC owned about 0.70% of Microbot Medical worth $160,000 as of its most recent filing with the SEC. 16.30% of the stock is owned by institutional investors and hedge funds.

About Microbot Medical

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.